← Back to Clinical Trials
Recruiting NCT06771999

NCT06771999 Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Pharmacist

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06771999
Status Recruiting
Phase
Sponsor Iuliu Hatieganu University of Medicine and Pharmacy
Condition Palliative Care
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-01-13
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Educational intervention by a clinical pharmacist

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-01-13 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Participation in this study consists in responding to some questions from two questionnaires in Romanian about how participants feel about deprescribing, participants' treatment and how participants understand medical information. After that, participants will receive a brochure and watch a video with some basic information about medications and participants' involvement in treatment decisions and in the next visit for cancer treatment participants will be asked to answer questions from one of the initial questionnaire.

Eligibility Criteria

Inclusion Criteria: * cancer patients in palliative treatment * ECOG 1-2 Exclusion Criteria: * cancer patients in curative treatment * ECOG 3-4 * cognitive impairment

Contact & Investigator

Central Contact

Mihaela I Clinical pharmacist, PhD student

✉ miha.onea@yahoo.com

📞 0741167906

Frequently Asked Questions

Who can join the NCT06771999 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Palliative Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06771999 currently recruiting?

Yes, NCT06771999 is actively recruiting participants. Contact the research team at miha.onea@yahoo.com for enrollment information.

Where is the NCT06771999 trial being conducted?

This trial is being conducted at Baia Mare, Romania.

Who is sponsoring the NCT06771999 clinical trial?

NCT06771999 is sponsored by Iuliu Hatieganu University of Medicine and Pharmacy. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology